obesity drug news today glp-1 World Health Organization recommends drugs for Study predicts 16 new obesity
Description
Interestingly, agmatine, a metabolite produced by the gut bacterium Bacteroides vulgatus was shown to impair ovarian function by inhibiting GLP-1 secretion through activation of the farnesoid X receptor (FXR) (Yun et al., 2024)
JACC 65(20):21592169 Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P (2017) Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: effects of weight loss and exercise
Diabetes indications and obesity indications are often treated differently by insurance plans
Battery efficiency and data usage matter as well
In the obesity trial, serious adverse events (SAEs) occurred in 4% of participants with retatrutide use overall (06% across groups) vs
